Moreover, compared to NACT-ESCC, hypoxia genes (e.g., LDHA, HIF1A, and EPO) were highly expressed in SA-ESCC patients, implying that chemotherapy affects the hypoxic microenvironment. The gene discussed is HIF1A; the disease is esophageal squamous cell carcinoma.